3,253 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 587 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,253
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$517M
2 +$511M
3 +$381M
4
JP Morgan Chase
JP Morgan Chase
New York
+$314M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$271M
Name Holding Trade Value Shares
Change
Change in
Stake
2176
$893K
2177
$892K
2178
$891K
2179
$890K
2180
$889K
2181
$888K
2182
$885K
2183
$884K
2184
$881K
2185
$880K
2186
$878K
2187
$878K
2188
$877K
2189
$876K
2190
$872K
2191
$871K
2192
$870K
2193
$869K
2194
$868K
2195
$867K
2196
$864K
2197
$864K
2198
$863K
2199
$863K
2200
$862K